首页 | 本学科首页   官方微博 | 高级检索  
     检索      

肺结核合并乙肝病毒无症状携带者的抗结核治疗
引用本文:赵刚,张吉林,等.肺结核合并乙肝病毒无症状携带者的抗结核治疗[J].北华大学学报(自然科学版),2000,1(6):515-516.
作者姓名:赵刚  张吉林
作者单位:[1]吴江市第一人民医院,江苏吴江215200 [2]北华大学医学院,吉林吉林132001
摘    要:目的 探讨肺结核合并乙肝病毒无症状携带者(ASC)抗结核治疗对肝功能的影响。方法 采用2HRZ/4-7HRE抗结核治疗,用生化自动分析仪观察肝功能改变。结果 ALT和AST轻度升高12/67,STB轻度升高2/67。经保肝治疗及密切监测肝功能改变后,大多数顺利地完成了抗结核治疗。结论 经密切监护,肺结核合并ASC者的抗结核治疗是安全的。

关 键 词:肺结核  乙肝病毒无症状携带者  抗结核药  抗结核治疗  肝功能  药物性肝炎

Treatment of Antituberculous Agents in the Patients with Pulmonary Tuberculosis and Asymptomatic Carrier of HBV
Zhao Gang ,Zhang Jilin ,Song Yuguo.Treatment of Antituberculous Agents in the Patients with Pulmonary Tuberculosis and Asymptomatic Carrier of HBV[J].Journal of Beihua University(Natural Science),2000,1(6):515-516.
Authors:Zhao Gang  Zhang Jilin  Song Yuguo
Institution:Zhao Gang 1,Zhang Jilin 2,Song Yuguo 3
Abstract:Objective To probe hepatic functional influence on the patient with pulmonary tuberculosis and asymptomatic carrier (ASC) of HBV in the therapy of antituberculous agents. Methods Observe hepatic functional changes of those patients by means of biochemical automatic analystor in the therapy of 2HRSZ/4 7HRE. Results The slight lifted value of ALT and AST was observed in 12/67 cases. The slight increased value of serum total bilirubin (STB) was observed in 2/67 cases. Taken protective hepatic functional medicine and monitored closely hepatic function most of those patients received smoothly antituberculous agents. Conclusion Monitored closely hepatic function is safe that the patients with pulmonary tuberculosis and ASC of HBV receives the therapy of 2HRSZ/4 7HRE.
Keywords:Pulmonary tuberculosis  Asymptomatic carrier of Hepatitis B Virus  Antituberculous agents  
本文献已被 CNKI 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号